Atrial Fibrillation in the Elderly

Area of Science:

• Cardiology
• Geriatrics
• Electrophysiology

Background:

• Atrial fibrillation (AF) is the most common sustained arrhythmia in adults, increasing with age.
• AF significantly elevates stroke and embolic event risk, necessitating aggressive management, especially in the elderly.
• Treatment goals for elderly AF patients include symptom alleviation, stroke prevention, and minimizing polypharmacy risks.

Purpose of the Study:

• To outline optimal treatment strategies for atrial fibrillation in the elderly population.
• To emphasize stroke prevention and symptom management while considering the risks of polypharmacy.
• To guide therapeutic decisions regarding rate control, anticoagulation, and rhythm control in older adults with AF.

Main Methods:

• Focus on optimizing rate control using atrioventricular (AV) nodal-blocking agents.
• Individualize anticoagulation decisions by balancing stroke risk against bleeding risk.
• Consider AV nodal ablation with pacemaker implantation for refractory cases.
• Reserve antiarrhythmic therapy for symptomatic patients, emphasizing continued anticoagulation.

Main Results:

• Rate control with AV nodal blockers is a primary strategy.
• Individualized anticoagulation is crucial, weighing stroke vs. bleeding risks.
• AV nodal ablation with pacing is a safe and effective rate control method for elderly patients.
• Invasive rhythm control procedures carry high risks in the elderly and are generally not recommended.

Conclusions:

• Aggressive management of atrial fibrillation in the elderly is essential for preventing stroke and improving quality of life.
• Rate control and individualized anticoagulation are cornerstones of AF treatment in older adults.
• Long-term anticoagulation is recommended even when sinus rhythm is achieved, due to persistent stroke risk.